Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Wound Dressing Products Market $17.1 Billion by 2029

The global market for wound dressing products projected to reach $17.1 billion by 2029, growing steadily at a CAGR of 4.5% over the forecast period, driven by technological advancements, rising geriatric population, and age-related chronic diseases worldwide.

  • Other factors driving the market growth include rising incidences of wound infections, growing public awareness, and increasing healthcare expenditure around the globe.
Global Wound Dressing Products Market

Wound healing is the result of interactions among cytokines, growth factors, blood and the extracellular matrix. Based on the wound type, suitable dressing material must be used.

  • Wound dressings that create and maintain a moist environment, however, are now considered to provide the optimal conditions for wound healing.
    • Major advances in the understanding of the basic science behind wound healing have led to an explosion in new wound care technologies and improvements in existing products.
      • With the advancement in technology, more than 3000 products have been developed to treat different types of wounds by targeting various aspects of healing process.

Traditionally wet-to-dry gauze has been used to treat wounds. Traditional wound dressing products including gauze, lint, plasters, bandages (natural or synthetic) and cotton wool are dry and used as primary or secondary dressings for protecting the wound from contamination.

  • Since traditional dressings fail to provide moist environment to the wound they have been replaced by modern dressings with more advanced formulations.
    • Medicated dressings incorporated drugs help cleaning or debriding agents for necrotic tissue, antimicrobials which prevents infection and promotes tissue regeneration.
    • Composite dressings are versatile and convenient for both partial and full thickness wounds, but have less flexibility and they are more expensive.
Wound Dressings Market

The advanced wound dressing products market encompasses a medley of different wound dressings, including alginates, film dressings, hydrocolloids, hydrogels, contact layers and antimicrobials such as some absorbing wound exudate, others providing moisture to the wound, and some doing a combination of both.

  • Modern wound dressing are focused to keep the wound from dehydration and promote healing. Based on the cause and type of wound, numerous products are available in the market.
    • Modern wound dressings are usually based on synthetic polymers, such as gauze and tulle dressings, films, foam, hydrogel and hydrocolloids.
      • These dressings act as a barrier against penetration of bacteria to the wound environment.
  • Bioactive dressings is produced from biomaterials known for their biocompatibility, biodegradability and non-toxic nature and are derived generally from natural tissues or artificial sources such as collagen, hyaluronic acid, chitosan, alginate and elastin.
    • In the biologics segment, amniotic tissue grafts are a fast-growing technology, with positive clinical outcomes and the rapid introduction of new technology driving market growth.
      • Human skin or dermal equivalent (HSE) has two types of tissue engineered substitutes available, one mimics the layer of skin composed of Keratinocytes and fibroblast on collagen matrix (cell containing matrix).
        • It contains only the dermal elements with fibroblast on collagen matrix (Acellular matrix).

The global wound dressing market report provides market size ($million 2019 to 2029), market share, growth trends and forecast (CAGR%, 2023 to 2029). 

The global wound dressing products market segmented by product [traditional wound dressings (wound closure products, basic wound care, anti-infective dressings), advanced wound dressings (films, foams, hydrofiber, hydrocolloids, hydrogels, collagen, alginates)], and geography.

  • Based on the broader product categories, the traditional wound dressing products segment accounted for the largest share of total market, while the advanced wound dressing products segment anticipated to witness fastest growth rate throughout the forecast period.
  • Traditional dressings include natural or synthetic bandages of cotton wool and gauze, that are dry and do not provide a moist or liquid wound environment.
    • Traditional wound dressings are the more efficiently used primary wound care methods, low cost, accessible to a wider population throughout the globe, and commonly used within standard first aid boxes.
      • However, these are generally not referred for wounds caused by chronic diseases such as ulcers, diabetes, and other serious infections.
    • Among these, the basic wound care products (cotton gauze, sterile cotton, etc.) sub-segment held the largest revenue share, whereas anti-infective dressings (broad-spectrum antibiotics such as polymyxin, neomycin, penicillin, etc.) sub-segment to register highest CAGR in the coming years.
  • Over the next few years, the best growth opportunities will emerge in tissue sealants, foam and alginate wound dressings, growth factor healing agents, bioengineered tissue substitutes and negative pressure therapy systems. Synthetic wound dressings broadened into different products including hydrogels, tissue adhesives, foams, vapor-permeable films, alginates, and silicone meshes. Nonmedicated dressings are usually based on hydrocolloids and alginates, which are mainly presented as a gel, film, and laminar foam.
    • The foam dressings market has experienced significant growth and innovation in the last few years. The foam wound dressings represent both the largest product segment and the most significant growth driver for this market.
    • Foam dressings are semipermeable and either hydrophilic or hydrophobic with a bacterial barrier. They are composed of polyurethane or silicone-based, rendering them suitable for handling moderate-to-high volumes of wound exudate.
      • Foam dressings provide thermal insulation and maintain moisture to the wound, and prevent damage to the wound at the time of removal. These dressings may also be used as secondary dressings with hydrogel or alginate dressings, in conjunction with a topical antimicrobial agent for infected wounds. Moreover, polyaniline/polyurethane foam dressing carried an anti-biofilm lichen metabolite usnic acid indicated an improved antibiofilm activity of conducting polymer.
      • Foam dressings keep the wound moist, can absorb fluid, and can also protect the wound. They can be used on wounds with a moderate amount of exudate and should be avoided on dry wounds.
        • Recently, Mölnlycke Health Care AB outpaced Smith & Nephew plc with its Safetac technology, an adherent silicone adhesive that removes easily from the skin, used with the Mepilex foam product.
        • Smith & Nephew plc offers Allevyn Life, a next-generation silicone foam dressing with a quadrilobe shape and multilayer design for cushioning, masking and dressing change indication.

The global wound dressing market research report is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA) and Rest of the World.

  • In terms of geography, the North America region accounted for more than half of the advanced wound dressing products market. Product innovation and robust growth have intensified in the United States advanced wound care products market in recent years.
    • However, similar growth patterns have yet to be realized in the other geographic regions. The diversity of the wound dressings market is largely due to the varied infrastructure, healthcare systems, social acceptability (culture, traditions, etc.), affordability and availability among the parts of the world.

Major competitors operating in the global wound dressing products market and included in this report are 3M Company, B. Braun Melsungen AG, Coloplast A/S, Canova Tec, Inc., Derma Sciences, Inc., Kinetic Concepts, Inc., Lohmann & Rauscher, Inc., Medline Industries, Inc., Molnlycke Health Care AB, Paul Hartmann AG, Smith & Nephew plc, and Systagenix Wound Management, Ltd.

  • Product
    • Traditional Wound Dressings
    • Advanced Wound Dressings (Synthetic)
      • Alginates
      • Collagen
      • Films
      • Foams
      • Hydrofiber
      • Hydrocolloids
      • Hydrogels
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • 3M Company
    • B. Braun Melsungen AG
    • Coloplast A/S
    • Canova Tec, Inc.
    • Derma Sciences, Inc.
    • Kinetic Concepts, Inc.
    • Lohmann & Rauscher, Inc.
    • Medline Industries, Inc.
    • Molnlycke Health Care AB
    • Paul Hartmann AG
    • Smith & Nephew plc
    • Systagenix Wound Management, Ltd.

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com